|
| 35795722 | Characteristics of Atopic Dermatitis Patients Treated with Crisaborole: Real-World Data from a Large Healthcare Provider Database in Israel. | Clin Cosmet Investig Dermatol | 2022 |
| 35795722 | Characteristics of Atopic Dermatitis Patients Treated with Crisaborole: Real-World Data from a Large Healthcare Provider Database in Israel. | Clin Cosmet Investig Dermatol | 2022 |
| 26682988 | Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. | Immunity | 2015 |
| 26682988 | Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures. | Immunity | 2015 |
| 25093834 | Wnt pathway activation increases hypoxia tolerance during development. | PLoS One | 2014 |
| 25093834 | Wnt pathway activation increases hypoxia tolerance during development. | PLoS One | 2014 |
| 23981351 | A combined omics study on activated macrophages--enhanced role of STATs in apoptosis, immunity and lipid metabolism. | Bioinformatics | 2013 |
| 23981351 | A combined omics study on activated macrophages--enhanced role of STATs in apoptosis, immunity and lipid metabolism. | Bioinformatics | 2013 |
| 21262834 | Experimental selection of hypoxia-tolerant Drosophila melanogaster. | Proc Natl Acad Sci U S A | 2011 |
| 21262834 | Experimental selection of hypoxia-tolerant Drosophila melanogaster. | Proc Natl Acad Sci U S A | 2011 |
| 22206604 | Modularity detection in protein-protein interaction networks. | BMC Res Notes | 2011 |
| 22206604 | Modularity detection in protein-protein interaction networks. | BMC Res Notes | 2011 |
| 20936779 | A human MAP kinase interactome. | Nat Methods | 2010 |
| 20936779 | A human MAP kinase interactome. | Nat Methods | 2010 |
| 19812322 | An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction. | J Neurosci | 2009 |
| 19812322 | An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction. | J Neurosci | 2009 |
| 14638501 | Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. | Antimicrob Agents Chemother | 2003 |
| 14638501 | Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. | Antimicrob Agents Chemother | 2003 |
| 11796347 | Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. | Antimicrob Agents Chemother | 2002 |
| 11796347 | Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. | Antimicrob Agents Chemother | 2002 |
| 10601506 | Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. | N Engl J Med | 1999 |
| 10452644 | Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. | Clin Infect Dis | 1999 |
| 10497008 | Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy. | Clin Immunol | 1999 |
| 10601506 | Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. | N Engl J Med | 1999 |
| 10452644 | Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. | Clin Infect Dis | 1999 |
| 10497008 | Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy. | Clin Immunol | 1999 |
| 7991942 | Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention. | Res Immunol | 1994 |
| 7991942 | Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention. | Res Immunol | 1994 |
| 8517917 | Can AIDS be prevented by T-cell vaccination? | Immunol Today | 1993 |
| 8517917 | Can AIDS be prevented by T-cell vaccination? | Immunol Today | 1993 |
| 2963193 | T cell responses studied in a basal serum-free medium. | Methods Enzymol | 1987 |
| 2963193 | T cell responses studied in a basal serum-free medium. | Methods Enzymol | 1987 |
| 3155998 | A defined basal medium for study of in vitro T-cell responses. | Cell Immunol | 1985 |
| 3155998 | A defined basal medium for study of in vitro T-cell responses. | Cell Immunol | 1985 |
| 902403 | Immunologic defects in melanoma patients: lack of effect of BCG therapy. | Clin Bull | 1977 |
| 902403 | Immunologic defects in melanoma patients: lack of effect of BCG therapy. | Clin Bull | 1977 |
| 1251569 | Separation of two hepatitis B human antibody fractions by cold-ethanol precipitation. | Vox Sang | 1976 |
| 1251569 | Separation of two hepatitis B human antibody fractions by cold-ethanol precipitation. | Vox Sang | 1976 |